Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
Melania Tesio
Affiliations
Melania Tesio
1 UR LIB Lymphoma Immuno-Biology, Institut national de la Recherche Médicale (INSERM) U1111, Centre International de Recherche en Infectiologie, Lyon, France